Chronic exposure to μ-opioid agonists produces constitutive activation of μ-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment

Molecular Pharmacology

Volumn 60, Issue 1, 2001, Pages 53-62

  Liu, Jing Gen ^a   Prather, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CHLORNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE;

ANIMAL CELL; ARTICLE; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY;

EID: 0034955327     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.1.53     Document Type: Article

References (39)

1. A separation method for the adenylyl cyclase intracellular cyclic. AMP and cyclic-AMP phosphediesterase using tritium-labeled substrates
2. Adenylyl cyclase supersensitivity in opioid-withdrawn NG108-15 hybrid cells requires Gs but is not mediated by the Gsα subunit
3. Human herpes virus KSHV encodes a constitutively active G-protein coupled receptor linked to cell proliferation
4. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ
5. Differential opioid agonist regulation of the mouse μ-opioid receptor
6. 3) elevated basal signalling activity
7. Distinct differences between morphine- and [D-Ala2, N-MePhe4, Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation
8. 1 receptor subtypes delineate residues underlying activation properties
9. 50) of an enzymatic reaction
10. Differential regulation by guanine nucleotides of opioid agonist and antagonist receptor interactions
11. Inverse agonistic effect of ICI 174,864 on the cloned δ-opioid receptor: Role of G proteins and adenylyl cyclase activation
12. Drug efficacy at guanine nucleotide-binding regulatory protein linked receptors: Thermodynamic interpretations of negative antagonism and of receptor activity in the absence of ligand
13. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization
14. κ-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes
15. Morphine activates opioid receptors without causing their rapid internalization
16. Regulation of opioid receptor activities
17. Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins
18. Regulation of spontaneous activity of the δ-opioid receptor: Studies of inverse agonism in intact cells
19. Inverse agonism, pharmacological curiosity or potential therapeutic strategy
20. Constitutive activity of the δ-opioid receptor expressed in C6 glioma cells: Identification of non-peptide δ-inverse agonists
21. Drug addiction: A model for the molecular basis of neural plasticity
22. Differential desensitization of mu-and delta-opioid receptors in selected neural pathways following chronic morphine treatment
23. 3 cells
24. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties
25. 2+ channels in transfected rat pituitary cells
26. Opioid analgesics and antagonists
27. 2-adrenergic receptor: Extending the ternary complex model
28. Effects of sodium on agonist efficacy for G-protein activation in μ-opioid receptor-transfected CHO cells and rat thalamus
29. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance
30. 35S]thio)triphisphate to NG108-15 cell membranes: Characterization of agonist and inverse agonist effects
31. Constitutive μ-opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence
32. Calmodulin binding to the G protein-coupling domain of opioid receptors
33. 3) in morphine-pretreated cells
34. Functional dissociation of μ-opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction
35. Down-regulation of μ-opioid receptors by full but not partial agonists is independent of G protein coupling
36. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells
37. Mu opioid receptor phosphorylation, desensitization, and ligand efficacy
38. Ligand-induced changes in surface μ-opioid receptor number: Relationship to G protein activation?